Health Care

FDA Approves Second Drug to Help Women With Low Libido

FDA Approves Second Drug to Help Women With Low Libido”

According to Vyleesi manufacturer AMAG Pharmaceuticals, 5.8 million premenopausal American women suffer from decreased sexual desire.

"There are women who, for no known reason, have reduced sexual desire that causes marked distress, and who can benefit from safe and effective pharmacologic treatment", said Hylton Bone, director of the Center for Drug Evaluation and Research's Division of Bone, Reproductive and Urologic Products.

The approval from the Food and Drug Administration adds another drug - the other is a daily pill that received FDA clearance in 2015 - meant to raise women's sexual desires. The drug is self-administered through an auto-injector 45 minutes before having sex.

"They don't want to have desire all the time", she said.

"While HSDD is the most common female sexual dysfunction condition, it is largely under-recognized".

"Female sexual dysfunction is more complicated in some ways than male sexual dysfunction, so it's more hard to treat", said Dr. Nicole Cirino, co-director of the Menopause and Sexual Therapy Clinic at Oregon Health and Science University's Center for Women's Health.

Another difference between the drugs is that Addyi, an oral tablet, is taken once daily, whereas patients can take bremelanotide as needed, Krop added. Seventeen percent of those who took a placebo reported an increase in sexual desire. Side effects during the trial included headaches, flushing and nausea.

Because so many factors affect sexual desire, doctors must rule out other causes before diagnosing the condition, including relationship issues, medical problems and mood disorders.

The medication OK'd Friday by the Food and Drug Administration is only the second approved to increase sexual desire in a women, a market drugmakers have been trying to cultivate since the blockbuster success of Viagra for men in the late 1990s.

AMAG licensed Vyleesi from Palatin Technologies Inc. and under the terms of their agreement the FDA approval triggers a $60 million payment to Palatin, plus tiered royalties tied to sales milestones.

Vyleesi should also not be taken by anyone who is also taking the drug naltrexone, used to combat opioid dependency, because Vyleesi reduces naltrexone's effectiveness.

Women with high blood pressure or heart disease should not take the drug because blood pressure increases were observed during testing.

The Food and Drug Administration has approved a new drug to treat low sexual drive in women, the only one besides Addyi, which entered the market in 2015.

Keep an eye on this pre-market jumper throughout the day to see if the drug maker will recoup any of its market losses since the bell. She had no role in Vyleesi's development. "And I think we have to give physicians more credit than that". "In fact, that didn't happen at all".

Vyleesi will join Addyi in women's small list of drug options that can boost their libido. To them, prescribing a drug for HSDD misguidedly reduces the complexity of human sexuality to a biological issue.

Like this



24 June 2019
Eldorado buys Caesars in $17B mega casino deal
Of that amount, Eldorado will pay $8.40 per share in cash; the rest of the payment will be in the form of stock in Eldorado. But all of its top leadership will come from Eldorado, from Chairman Gary Carano and CEO Tom Reeg to other top spots.

24 June 2019
Meghan Markle's engagement ring has completely changed
He said: "It was interesting about the lip readers with Harry telling Meghan to turn around on the balcony". Royal commentators said the move was the final act in the division of the couples' public duties.

24 June 2019
Del Potro raises doubts over career after latest injury
" As you might know I fractured my right patella once again ", Juan Martin Del Potro said. A statement from del Potro's team said a "bone fragment" was removed during the surgery.

24 June 2019
Pompeo sets out to build global coalition against Iran
The trip comes as President Donald Trump called off a military strike on Iran to retaliate for Tehran's downing of a U.S. drone. Iran's president Hassan Rouhani maintains his country has complied with the deal and said it wouldn't immediately withdraw.

24 June 2019
Ford will release the most powerful modification of Mustang Shelby
A carbon fiber instrument panel is optional, and there are new door panel inserts in Dark Slate Miko suede with accent stitching. The GT500 is a far more powerful beast than the GT350 and GT350R, which uses a naturally aspirated version of the 5.2-liter V8.

24 June 2019
Rajasthan tent collapse kills 14 at religious event
The former chief minister of Rajasthan Vasundhara Raje Scindia also expressed grief over death of several people in the incident. He scurried from the stage within seconds as the structure came down, leading to a stampede-like situation, they said.

24 June 2019
RBI's deputy governor Viral Acharya quits six months before his term ends
In an unexpected development, RBI deputy governor Viral Acharya quit, almost six months ahead of the end of his three-year term. ET has independently confirmed that Acharya has quit and would be heading to the New York University to teach.

24 June 2019
The bodies of 7 missing climbers have been recovered in the Himalayas
The bodies have not been identified yet and it will be possible only after they are brought down to the base camp, Nimbadia said. A massive search was then launched by Indian authorities but operations were affected by bad weather and hard terrain.

24 June 2019
Young People Are Growing Horns Due to Mobile Phones, Technology
Yet another study made the case that the cause isn't genetic, but a result of the modern posture of staring down at tiny screens. A new study suggests that young people could be developing "horn-like spikes", aka bone spurs , on their skulls as a result.

24 June 2019
Methane gas found on Mars hints at possibility of life
However, the agency notes Curiosity does not contain instruments which can definitively say where the methane may have come from. In practical terms, NASA explains it as one billionth part of a volume of Martian air sample will be methane.